Recent developments include Ultralife's Q2 2026 earnings call and transcript, Q1 2026 earnings disclosures, and the completion of the Electrochem acquisition with secured financing. The company reported a 13% revenue rise in Q2 2025 and has undergone a rebranding initiative consolidating multiple sub-brands under the Ultralife master brand.

• Ultralife held its Q2 2026 earnings call and released the transcript detailing financial results and operational updates [N1].
• Q2 2026 earnings call highlights were published, providing key insights into company performance [N2].
• The company released its Q1 2026 earnings transcript and call highlights, discussing quarterly results [N3][N4].
• Ultralife completed the acquisition of Electrochem and secured financing to support the transaction as of March 24, 2026 [N5].
• In Q2 2025, Ultralife reported a 13% increase in revenue, reflecting growth in its business segments [N6].

Ultralife's strategic acquisition of Electrochem and its rebranding initiative may strengthen its market position and brand recognition. The company's focus on mission-critical battery and RF power solutions for government and defense customers provides a stable revenue base. Its diversified product portfolio and global sales channels support growth opportunities. The company's liquidity and compliance with credit covenants indicate financial discipline. Experienced leadership and governance structures support operational execution. Continued innovation in battery technology and communications systems could enhance competitive advantage [N1][N2][N5][S2].

Ultralife faces risks from reliance on government and defense spending, which can be subject to budgetary constraints and delays. The company operates in a competitive industry with rapid technological changes that may require significant R&D investment. Supply chain disruptions, raw material cost volatility, and regulatory compliance challenges could impact operations. The non-cash impairment charge related to rebranding indicates potential challenges in brand management. Debt levels and interest costs may constrain financial flexibility. Market concentration and customer dependence could pose risks if key contracts are lost or reduced [S2].

Ultralife's moat is supported by its specialized expertise in battery technology and communications systems, particularly for mission-critical applications in government and defense markets. The company's long-standing relationships with defense departments and OEMs, combined with proprietary technology and patents in rechargeable and primary battery cells, contribute to competitive differentiation. The recent acquisition of Electrochem enhances product breadth and technological capabilities. Additionally, the company's global sales channels and established brand presence in niche markets provide barriers to entry for competitors. However, the company operates in markets subject to government spending fluctuations and technological innovation risks, which require ongoing investment in R&D and customer relationships [S1][S2].

• Dependence on Government and Defense Spending: A significant portion of Ultralife's revenue comes from government and defense contracts, which are subject to budgetary and political risks that could affect demand and contract renewals.
• Technological and Market Competition: The battery and communications systems markets are highly competitive and rapidly evolving, requiring continuous innovation and investment to maintain technological leadership.
• Supply Chain and Raw Material Risks: Disruptions in supply chains or increases in raw material costs, including lithium and other battery components, could adversely affect production and margins.
• Regulatory and Safety Compliance: Manufacture and transportation of lithium batteries involve safety risks and regulatory requirements that could lead to increased costs or liabilities.
• Financial Leverage and Interest Costs: Ultralife carries long-term debt and must comply with credit agreement covenants; rising interest rates or inability to meet covenants could impact financial stability.

• Ultralife Corporation is a Delaware corporation headquartered in Newark, New York, USA [S1].
• The company designs and manufactures power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems, and accessories for government, defense, and commercial customers worldwide [S2].
• Ultralife operates two main segments: Battery & Energy Products and Communications Systems [S2].
• Battery & Energy Products segment includes Lithium 9-volt, cylindrical, thin cell and other non-rechargeable batteries, rechargeable batteries, uninterruptable power supplies, charging systems, and accessories [S2].
• Communications Systems segment includes RF amplifiers, power supplies, cable and connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, integrated communication systems for fixed or vehicle applications, and communications and electronics systems design [S2].
• The company sells products globally through OEMs, industrial and defense supply distributors, and directly to U.S. and foreign defense departments [S2].
• Ultralife completed the acquisition of Electrochem and secured financing for it as of March 24, 2026 [N5].
• The company underwent a rebranding initiative in October 2025 consolidating multiple sub-brands under the master brand Ultralife to enhance brand clarity and consistency [S2].
• As of June 30, 2026, Ultralife had cash and cash equivalents of approximately $6.7 million and total current assets of about $107.2 million, with current liabilities of approximately $37.4 million, resulting in a current ratio of 2.87 and a cash ratio of 0.25 [S2].
• Total assets were approximately $216.2 million and total liabilities about $84.8 million as of June 30, 2026 [S2].
• The company had long-term debt net of current portion of about $46.5 million as of June 30, 2026 [S2].
• For the quarter ended June 30, 2026, Ultralife reported revenue of approximately $47.9 million and net income of about $2.5 million [S2].
• Basic and diluted earnings per share for the quarter ended June 30, 2026 were $0.15 per share [S2].
• The company had approximately 16.66 million shares outstanding as of August 3, 2026 [S2].
• Revenue is recognized upon transfer of control to the customer, generally upon shipment or delivery, with no general right of return for customers [S2].
• Extended warranty contracts are offered on certain Communications Systems products for up to eight years, with deferred revenue recorded accordingly [S2].
• Ultralife's customer base includes significant government and defense contracts, with approximately 36% of revenue from government/defense and 64% from commercial customers in recent quarters [S2].
• Geographically, about 66% of revenue was from the United States and 34% from non-U.S. sources for the quarter ended March 31, 2026 [S2].
• The company maintains compliance with its credit agreement covenants, with borrowing rates around 6.11% as of June 30, 2026 [S2].
• Ultralife's board of directors includes experienced executives with expertise in battery technology, corporate governance, finance, and commercial leadership [S1].
• The company has a policy of director retirement at age 70 unless ownership thresholds are met, and maintains independent committees for audit, governance, and compensation [S1].
• Ultralife reported a non-cash impairment charge of $12.2 million in Q4 2025 related to the rebranding initiative reducing tradename and trademark intangible assets [S2].
• The company reported segment contribution as gross profit less direct SG&A and R&D expenses, used as a key performance indicator [S2].
• Recent earnings calls in Q1 and Q2 2026 provide detailed discussion of financial results and strategic initiatives [N1,N2,N3,N4].